PriceTargets.com logo

PetMed Express - PETS Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $3.50
  • Forecasted Upside: -29.58%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$4.97 As of 12/20/2024 06:31 PM ET
▼ -0.13 (-2.55%)

This chart shows the closing price for PETS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New PetMed Express Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PETS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PETS

Analyst Price Target is $3.50
▼ -29.58% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for PetMed Express in the last 3 months. The average price target is $3.50, with a high forecast of $3.50 and a low forecast of $3.50. The average price target represents a -29.58% upside from the last price of $4.97.

This chart shows the closing price for PETS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 2 investment analysts is to reduce stock in PetMed Express. This rating has held steady since July 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
9/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
11/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/7/2024Lake Street CapitalReiterated RatingBuy ➝ Hold$7.00 ➝ $3.50
6/12/2024Lake Street CapitalLower TargetBuy ➝ Buy$9.00 ➝ $7.00
6/12/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$6.50 ➝ $3.50
11/16/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$7.00 ➝ $6.50
10/31/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$10.00 ➝ $7.00
10/19/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$17.00 ➝ $10.00
5/25/2023Lake Street CapitalInitiated CoverageBuy$20.00
3/23/2023Morgan StanleyLower TargetUnderweight$18.00 ➝ $17.00
11/8/2022Morgan StanleyLower TargetUnderweight$19.00 ➝ $18.00
7/26/2022Morgan StanleyLower TargetUnderweight$20.00 ➝ $19.00
1/25/2022Morgan StanleyLower TargetUnderweight$25.00 ➝ $21.00
1/20/2022SidotiUpgradeNeutral ➝ Buy$32.00
11/18/2021Morgan StanleyInitiated CoverageUnderweight$25.00
9/30/2021Jefferies Financial GroupInitiated CoverageHold$28.00
6/3/2021SidotiDowngradeBuy ➝ Neutral$39.00
3/5/2021SidotiUpgradeNeutral ➝ Buy
1/27/2021SidotiDowngradeBuy ➝ Neutral
8/19/2020SidotiUpgradeNeutral ➝ Buy$37.00 ➝ $41.00
4/9/2020SidotiDowngradeBuy ➝ Neutral$31.00
3/12/2020SidotiUpgradeNeutral ➝ Buy$31.00
2/24/2020SidotiDowngradeBuy ➝ Neutral$31.00
1/2/2020SidotiReiterated RatingBuy$29.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.92 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 4 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
6/24/2024
  • 4 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 6 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
8/23/2024
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/22/2024
  • 6 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 3 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/21/2024
  • 5 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 5 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

PetMed Express logo
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Read More

Today's Range

Now: $4.97
Low: $4.94
High: $5.35

50 Day Range

MA: $4.78
Low: $3.85
High: $6.60

52 Week Range

Now: $4.97
Low: $2.90
High: $7.79

Volume

543,649 shs

Average Volume

339,618 shs

Market Capitalization

$102.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71

Frequently Asked Questions

What sell-side analysts currently cover shares of PetMed Express?

The following Wall Street sell-side analysts have issued reports on PetMed Express in the last year: Lake Street Capital, Morgan Stanley, and StockNews.com.
View the latest analyst ratings for PETS.

What is the current price target for PetMed Express?

0 Wall Street analysts have set twelve-month price targets for PetMed Express in the last year. Their average twelve-month price target is $3.50, suggesting a possible downside of 29.6%. Morgan Stanley has the highest price target set, predicting PETS will reach $3.50 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $3.50 for PetMed Express in the next year.
View the latest price targets for PETS.

What is the current consensus analyst rating for PetMed Express?

PetMed Express currently has 1 sell rating and 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for PETS.

What other companies compete with PetMed Express?

Other companies that are similar to PetMed Express include CarParts.com, Amazon.com, Netflix, Booking and Expedia Group. Learn More about companies similar to PetMed Express.

How do I contact PetMed Express' investor relations team?

PetMed Express' physical mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company's listed phone number is (561) 526-4444 and its investor relations email address is [email protected]. The official website for PetMed Express is www.1800petmeds.com. Learn More about contacing PetMed Express investor relations.